Table 4 Comparison of the sensitivity in a viral vaccine crude harvest versus sensitivity of the NIH in vivo tests.

From: Sensitivity and breadth of detection of high-throughput sequencing for adventitious virus detection

NIH virus

In vivo LOD (TCID50, as described previously)9

Sensitivity of the in vivo assay (GC, determined by Clean Cell)

Sensitivity of the HTS assay (GC)

Adenoviridae

   

 Adenovirus 5

NT

NT

90

 Adenovirus 41

NT

NT

9000

Flaviviridae

   

 Bovine Viral Diarrhea Virus

Not detected

≥3.39 × 108

90

Herpesviridae

   

 Herpes Simplex Virus Type 1

100

3.4 × 104

900

 Simian Cytomegalovirus

NT

NT

90

 Orthomyxoviridae

   

 Influenza A Virus

10−4

5.46 × 10−4*

90*

Paramyxoviridae

   

 Bovine Parainfluenza Virus Type 3

Not detected

≥8.67 × 107

90

 Mumps Virus

Undiluted

1.12 × 109

900

 Measles Morbillivirus

Not detected

≥4.00 × 108

900

Picornaviridae

   

 Coxsackievirus A16

105

3.03 × 108

9000

 Coxsackievirus B3

1

3.0 × 104

900

 Echovirus 11

Not detected

≥6.29 × 109

900

 Rhinovirus 2

NT

NT

9000

Polyomaviridae

   

 Simian Virus 40

NT

NT

9000

Rhabdoviridae

   

 Vesicular Stomatitis Virus

10−4

1.28 × 10−4*

90*

Togaviridae

   

 Rubella Virus

Not detected

≥2.45 × 107

900

  1. HTS assay is corrected for the volume used for extraction (900 μL).
  2. GC genome copy, HTS high-throughput sequencing, ND Not detected, NIH National Institutes of Health, NTNot tested.
  3. *viruses with lower sensitivity using the HTS test compared to the in vivo assay.